Carl Byrnes
Stock Analyst at Northland Capital Markets
(2.82)
# 823
Out of 5,180 analysts
27
Total ratings
46.67%
Success rate
45.96%
Average return
Main Sectors:
Stocks Rated by Carl Byrnes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCEL AVITA Medical | Initiates: Outperform | $10 | $3.70 | +170.27% | 1 | Mar 5, 2026 | |
| BWAY BrainsWay | Maintains: Outperform | $9.5 → $12 | $13.29 | -13.47% | 5 | Nov 12, 2025 | |
| SNWV SANUWAVE Health | Initiates: Outperform | $55 | $17.29 | +218.10% | 1 | Sep 3, 2025 | |
| BLFS BioLife Solutions | Maintains: Outperform | $28 → $31 | $19.08 | +62.47% | 2 | Jan 8, 2025 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $13 | $4.00 | +212.50% | 1 | Oct 25, 2024 | |
| MDAI Spectral AI | Initiates: Outperform | $6 | $1.47 | +308.16% | 1 | Aug 12, 2024 | |
| COCH Envoy Medical | Initiates: Outperform | n/a | $0.67 | - | 1 | Dec 21, 2023 | |
| AMRN Amarin Corporation | Maintains: Market Perform | $40 → $25 | $14.46 | +72.89% | 1 | Jul 19, 2023 | |
| CDIO Cardio Diagnostics Holdings | Initiates: Outperform | $240 | $1.95 | +12,207.69% | 1 | May 22, 2023 | |
| VTVT vTv Therapeutics | Maintains: Outperform | $60 → $80 | $40.37 | +98.17% | 4 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $23 | $3.95 | +482.28% | 3 | Jul 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $30 → $24 | $2.74 | +775.91% | 4 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $2,000 | $2.73 | +73,160.07% | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $0.80 | - | 1 | Sep 27, 2017 |
AVITA Medical
Mar 5, 2026
Initiates: Outperform
Price Target: $10
Current: $3.70
Upside: +170.27%
BrainsWay
Nov 12, 2025
Maintains: Outperform
Price Target: $9.5 → $12
Current: $13.29
Upside: -13.47%
SANUWAVE Health
Sep 3, 2025
Initiates: Outperform
Price Target: $55
Current: $17.29
Upside: +218.10%
BioLife Solutions
Jan 8, 2025
Maintains: Outperform
Price Target: $28 → $31
Current: $19.08
Upside: +62.47%
TriSalus Life Sciences
Oct 25, 2024
Initiates: Outperform
Price Target: $13
Current: $4.00
Upside: +212.50%
Spectral AI
Aug 12, 2024
Initiates: Outperform
Price Target: $6
Current: $1.47
Upside: +308.16%
Envoy Medical
Dec 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $0.67
Upside: -
Amarin Corporation
Jul 19, 2023
Maintains: Market Perform
Price Target: $40 → $25
Current: $14.46
Upside: +72.89%
Cardio Diagnostics Holdings
May 22, 2023
Initiates: Outperform
Price Target: $240
Current: $1.95
Upside: +12,207.69%
vTv Therapeutics
Aug 17, 2022
Maintains: Outperform
Price Target: $60 → $80
Current: $40.37
Upside: +98.17%
Jul 26, 2021
Initiates: Outperform
Price Target: $23
Current: $3.95
Upside: +482.28%
May 5, 2021
Maintains: Market Perform
Price Target: $30 → $24
Current: $2.74
Upside: +775.91%
Oct 22, 2018
Initiates: Outperform
Price Target: $2,000
Current: $2.73
Upside: +73,160.07%
Sep 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $0.80
Upside: -